Reference
  1. Dicuonzo F, Purciariello S, De Marco A, et al. MR evaluation of encephalic leukoaraiosis in sudden sensorineural hearing loss (SSNHL) patients. Neurol Sci. 2019 Feb;40(2):357-362.
  2. Wu CS, Lin HC, Chao PZ. Sudden sensorineural hearing loss: evidence from Taiwan. Audiol Neurootol 2006; 11:151–6.
  3. Teranishi M, Katayama N, Uchida Y, Tominaga M, Nakashima T. Thirty-year trends in sudden deafness from four nationwide epidemiological surveys in Japan. Acta Otolaryngol 2007;127:1259–65.
  4. Merchant SN, Durand ML, Adams JC. Sudden deafness: is it viral? ORL J Otorhinolaryngol Relat Spec 2008; 70:52-60.
  5. Ryan AF, Harris JP, Keithley EM. Immune-mediated hearing loss: basic mechanisms and options for therapy. Acta Otolaryngol Suppl 2002; 548:38-43.
  6. De Stefano ME, Herrero MT. The multifaceted role of metalloproteinases in physiological and pathological conditions in embryonic and adult brains. Prog Neurobiol. 2017 Aug; 155:36-56.
  7. Chen R, Cai X, Liu J, Bai B, Li X. Sphingosine 1-phosphate promotes mesenchymal stem cell-mediated cardioprotection against myocardial infarction via ERK1/2-MMP-9 and Akt signaling axis. Life Sci. 2018 Dec 15; 215:31-42.
  8. Oku T, Shimada K, Kenmotsu H, et al. Stimulation of Peritoneal Mesothelial Cells to Secrete Matrix Metalloproteinase-9 (MMP-9) by TNF-α: A Role in the Invasion of Gastric Carcinoma Cells. Int J Mol Sci. 2018 Dec 9;19(12).
  9. Liu Y, Tie N, Bai L. Serum Levels of MDC and MMP-9 and the Relationship Between Serum Levels and Disease Activity in the Patients with Systemic Lupus Erythematosus. Pak J Med Sci. 2015 Jul-Aug;31(4):803-6
  10. Jönsson S, Lundberg AK, Jonasson L. Overexpression of MMP-9 and its inhibitors in blood mononuclear cells after myocardial infarction–is it associated with depressive symptomatology? PLoS One. 2014 Aug 25;9(8):e105572
  11. Stanciu AE, Zamfir-Chiru-Anton A, Stanciu MM, Popescu CR, Gheorghe DC. Serum Level of Matrix Metalloproteinase-9 in Patients with Head and Neck Squamous Cell Carcinoma. Clin Lab. 2016 Aug 1;62(8):1569-1574.
  12. [removed for blind peer review]
  13. Chinese Guidelines for the diagnosis and treatment of Sudden Sensorineural Hearing loss(2015). Chinese Journal of Otorhinolaryngology Head and Neck Surgery,2015(6):443-447.
  14. Chung JH, Cho SH, Jeong JH, Park CW, Lee SH. Multivariate analysis of prognostic factors for idiopathic sudden sensorineural hearing loss in children. Laryngoscope . 2015;125(9):2209‐2215. doi:10.1002/lary.25196
  15. Kim JY, Han JJ, Sunwoo WS, et al. Sudden sensorineural hearing loss in children and adolescents: Clinical characteristics and age-related prognosis. Auris Nasus Larynx . 2018;45(3):447‐455. doi:10.1016/j.anl.2017.08.010
  16. Kuhn M, Heman-Ackah SE, Shaikh JA, Roehm PC. Sudden sensorineural hearing loss: a review of diagnosis, treatment, and prognosis. Trends Amplif . 2011;15(3):91‐105. doi:10.1177/1084713811408349
  17. Choi YC, Daiakas MC. Expression of matrix metalloproteinases in the muscie of patients with inflammatory myopathies[J]. Neuroiogy, 2O00.54(1) :65_71.
  18. Marcucci R, Alessandrello Liotta A, Cellai AP, et al. Cardiovascular and thrombophilic risk factors for idiopathic sudden sensorineural hearing loss. J Thromb Haemost. 2005 May;3(5):929-34.
  19. Kundu S, Tyagi N, Sen U, Tyagi SC. Matrix imbalance by inducing expression of metalloproteinase and oxidative stress in cochlea of hyperhomocysteinemic mice. Mol Cell Biochem. 2009 Dec;332(1-2):215-24.
  20. Robak E, Wierzbowska A, Chmiela M, et al. Circulating Total and Active Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinases-1 in Patients with Systemic Lupus Erythomatosus[J]. Mediators of Inflammation. 2006;2006(1):17898.
  21. Vira H, Pradhan V, Umare V, et al. Role of polymorphisms in MMP-9 and TIMP-1 as biomarkers for susceptibility to systemic lupus erythematosus patients. Biomark Med. 2019 Jan;13(1):33-43.
  22. Opstad TB, Arnesen H, Pettersen AÅ, Seljeflot I. The MMP-9 -1562 C/T polymorphism in the presence of metabolic syndrome increases the risk of clinical events in patients with coronary artery disease. PLoS One. 2014;9(9):e106816. Published 2014 Sep 5. doi:10.1371/journal.pone.0106816
  23. Thammineni KL, Thakur GK, Kaur N, Banerjee BD. Significance of MMP-9 and VEGF-C expression in North Indian women with breast cancer diagnosis. Mol Cell Biochem. 2019;457(1-2):93‐103. doi:10.1007/s11010-019-03515-w
  24. Matache C, Stefanescu M, Dragomir C, et al. Matrix metalloproteinase-9 and its natural inhibitor TIMP-1 expressed or secreted by peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Journal of Autoimmunity . 2003;20(4):323–331